InsiderWatch
Get Started

J. Anthony Ware Insider Trades

Director

Director at First Tracks Biotherapeutics, Inc.. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.

On EDGAR, this filer has 19 Form 4 filings on record since 2017, the latest on Sep 4, 2026. Full history on sec.gov

$0

Bought

$1.8M

Sold

0 / 1

Buys / Sells

1

Companies

Companies

  • TRAXDirector

    First Tracks Biotherapeutics, Inc.

    1 sell, $1.8M · 1 graded alert

Reported Trades

Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.

FiledCompanyTradeValue
Sep 4, 2026TRAXDirectorsell71.5% of stake$1.8M

How to Read This Page

These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. Several insiders buying at the same company in the same week is cluster buying, the pattern the research literature rates highest. The window here is 180 days; the full filing history lives on EDGAR.

Get this insider's next buy the minute it files

InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.

Try free for 7 days

Every call scored in public, misses included.